|
Aug 5
|
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
|
|
Aug 5
|
Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
|
Aug 1
|
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
|
|
Jul 29
|
Viatris 2023 Sustainability Report: Empowering Healthcare Workers
|
|
Jul 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Jul 23
|
Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain
|
|
Jun 26
|
Here's Why You May Invest in Theravance (TBPH) Stock Now
|
|
Jun 25
|
Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List
|
|
Jun 14
|
Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
|
|
May 14
|
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
|
|
May 10
|
Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...
|
|
May 10
|
Q1 2024 Viatris Inc Earnings Call
|
|
May 9
|
Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast
|
|
May 9
|
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
|
|
May 9
|
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 9
|
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
|
|
May 9
|
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
|
|
May 9
|
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
|
|
May 8
|
Why Earnings Season Could Be Great for Viatris (VTRS)
|